More about Sumitomo Chemical India Limited
Fundamentals for Sumitomo Chemical India Limited
Regulatory Filings for Sumitomo Chemical India Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Sumitomo Chemical India Limited
Business Operations:
Sector: Basic MaterialsIndustry: Agricultural Inputs
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company exports its products. Sumitomo Chemical India Limited was incorporated in 2000 and is headquartered in Mumbai, India. The company is a subsidiary of Sumitomo Chemical Company Limited.
Revenue projections:
Investors are expected to be cautious with SUMICHEM, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.
Financial Ratios:
| currentRatio | 0.00000 |
|---|---|
| forwardPE | 33.26461 |
| debtToEquity | 1.82000 |
| earningsGrowth | -0.12600 |
| revenueGrowth | -0.11500 |
| grossMargins | 0.40964 |
| operatingMargins | 0.14569 |
| trailingEps | 10.86000 |
| forwardEps | 14.89571 |
SUMICHEM's low earnings and revenue growth highlight potential profit shrinkage. This suggests that the company may struggle to maintain its financial performance, raising concerns about its future profitability.
SUMICHEM's negative gross and operating margins highlight that the company is incurring losses, unable to generate profit from production or operations. This could be a sign of rising costs or declining revenues, impacting its financial outlook.
SUMICHEM's forward EPS being higher than its trailing EPS indicates that the company is expected to achieve greater profitability this financial year. This suggests improving earnings and a stronger financial position compared to the previous year's performance.
Price projections:
SUMICHEM's price has frequently been situated near the lower end of analysts' projections. This trend indicates that the stock is struggling to meet expectations, which could signal a need for improvements in performance or investor confidence.
Recommendation changes over time:
Analysts' buy bias for SUMICHEM signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to SUMICHEM, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap